药品注册申请号:208699
申请类型:ANDA (仿制药申请)
申请人:GLENMARK PHARMS LTD
申请人全名:GLENMARK PHARMACEUTICALS LTD
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;10MG No No AB 2019/06/27 2019/06/27 Prescription
002 EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;20MG No No AB 2019/06/27 Prescription
003 EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;40MG No No AB 2019/06/27 Prescription
004 EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;80MG No No AB 2019/06/27 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2022/02/02 SUPPL-2(补充) Approval Labeling STANDARD
2020/01/24 SUPPL-1(补充) Approval Labeling STANDARD
2019/06/27 ORIG-1(原始申请) Approval STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:EZETIMIBE; SIMVASTATIN 剂型/给药途径:TABLET;ORAL 规格:10MG;10MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
021687 001 NDA VYTORIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;10MG Prescription Yes No AB 2004/07/23 ORGANON
200909 001 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;10MG Prescription No No AB 2017/04/26 DR REDDYS LABS SA
202968 001 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;10MG Prescription No No AB 2017/04/26 WATSON LABS INC
208831 001 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;10MG Prescription No No AB 2017/11/21 AMNEAL PHARMS CO
209222 001 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;10MG Prescription No No AB 2017/12/22 ALKEM LABS LTD
208699 001 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;10MG Prescription No No AB 2019/06/27 GLENMARK PHARMS LTD
200082 001 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;10MG Prescription No No AB 2020/12/17 AUROBINDO PHARMA USA
活性成分:EZETIMIBE; SIMVASTATIN 剂型/给药途径:TABLET;ORAL 规格:10MG;20MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
021687 002 NDA VYTORIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;20MG Prescription Yes No AB 2004/07/23 ORGANON
200909 002 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;20MG Prescription No No AB 2017/04/26 DR REDDYS LABS SA
202968 002 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;20MG Prescription No No AB 2017/04/26 WATSON LABS INC
208831 002 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;20MG Prescription No No AB 2017/11/21 AMNEAL PHARMS CO
209222 002 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;20MG Prescription No No AB 2017/12/22 ALKEM LABS LTD
208699 002 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;20MG Prescription No No AB 2019/06/27 GLENMARK PHARMS LTD
200082 002 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;20MG Prescription No No AB 2020/12/17 AUROBINDO PHARMA USA
活性成分:EZETIMIBE; SIMVASTATIN 剂型/给药途径:TABLET;ORAL 规格:10MG;40MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
021687 003 NDA VYTORIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;40MG Prescription Yes No AB 2004/07/23 ORGANON
200909 003 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;40MG Prescription No No AB 2017/04/26 DR REDDYS LABS SA
202968 003 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;40MG Prescription No No AB 2017/04/26 WATSON LABS INC
208831 003 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;40MG Prescription No No AB 2017/11/21 AMNEAL PHARMS CO
209222 003 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;40MG Prescription No No AB 2017/12/22 ALKEM LABS LTD
208699 003 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;40MG Prescription No No AB 2019/06/27 GLENMARK PHARMS LTD
200082 003 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;40MG Prescription No No AB 2020/12/17 AUROBINDO PHARMA USA
活性成分:EZETIMIBE; SIMVASTATIN 剂型/给药途径:TABLET;ORAL 规格:10MG;80MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
021687 004 NDA VYTORIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;80MG Prescription Yes Yes AB 2004/07/23 ORGANON
200909 004 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;80MG Prescription No No AB 2017/04/26 DR REDDYS LABS SA
202968 004 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;80MG Prescription No No AB 2017/04/26 WATSON LABS INC
208831 004 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;80MG Prescription No No AB 2017/11/21 AMNEAL PHARMS CO
209222 004 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;80MG Prescription No No AB 2017/12/22 ALKEM LABS LTD
208699 004 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;80MG Prescription No No AB 2019/06/27 GLENMARK PHARMS LTD
200082 004 ANDA EZETIMIBE AND SIMVASTATIN EZETIMIBE; SIMVASTATIN TABLET;ORAL 10MG;80MG Prescription No No AB 2020/12/17 AUROBINDO PHARMA USA
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database